MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Erasca, Inc. (ERAS)

Erasca, Inc. (ERAS)

|||

Cash Flow Overview

Change in Cash
-$26,549K
Free Cash flow
-$27,419K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of common...
    • In-process research and developm...
    • Sales of marketable securities
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Net loss
    • In-process research and developm...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-183,440 -29,092 -30,612 -64,842
Depreciation and amortization
723 743 755 1,609
Stock-based compensation expense
8,460 5,823 5,965 13,111
In-process research and development expenses
150,000 0 2,000 7,500
Accretion on marketable securities, net
746 580 1,022 3,485
Realized gain from sales of marketable securities, net
47 NaN NaN NaN
Prepaid expenses and other current and long-term assets
-175 -2,176 903 -516
Accounts payable
1,182 -2,048 1,366 1,195
Accrued expenses and other current and long-term liabilities
-3,269 1,670 1,190 -6,628
Operating lease assets and liabilities, net
421 403 397 1,062
Net cash used in operating activities
-27,383 -21,711 -21,658 -52,086
Purchases of marketable securities
253,170 42,230 41,540 67,204
Maturities of marketable securities
58,550 66,950 71,250 122,827
Sales of marketable securities
100,826 NaN NaN NaN
In-process research and development
150,000 0 4,000 5,500
Purchases of property and equipment
36 9 6 113
Net cash (used in) provided by investing activities
-243,830 24,711 25,704 50,010
Proceeds from issuance of common stock in underwritten offering
258,750 NaN NaN NaN
Issuance costs associated with underwritten offering
16,044 NaN NaN NaN
Proceeds from the exercise of stock options
1,958 255 41 76
Proceeds from issuance of common stock under the employee stock purchase plan
NaN 320 0 404
Net cash provided by financing activities
244,664 575 41 480
Net (decrease) increase in cash, cash equivalents, and restricted cash
-26,549 3,575 4,087 -1,596
Cash, cash equivalents and restricted cash at beginning of the period
74,213 70,638 68,147 NaN
Cash, cash equivalents and restricted cash at end of the period
47,664 74,213 70,638 NaN
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock in...$258,750K Proceeds from theexercise of stock options$1,958K Net cash provided byfinancing activities$244,664K Canceled cashflow$16,044K Net (decrease)increase in cash, cash...-$26,549K Canceled cashflow$244,664K Sales of marketablesecurities$100,826K Maturities of marketablesecurities$58,550K In-process research anddevelopment expenses$150,000K Stock-based compensationexpense$8,460K Accounts payable$1,182K Depreciation andamortization$723K Prepaid expenses andother current and...-$175K Issuance costsassociated with...$16,044K Net cash (used in)provided by investing...-$243,830K Canceled cashflow$159,376K Net cash used inoperating activities-$27,383K Canceled cashflow$160,540K Purchases of marketablesecurities$253,170K In-process research anddevelopment$150,000K Purchases of property andequipment$36K Net loss-$183,440K Accrued expenses andother current and...-$3,269K Accretion on marketablesecurities, net$746K Operating lease assets andliabilities, net$421K Realized gain from salesof marketable...$47K